Narula G, Pradhan ND, Arora B, Banavali S .from the Pediatric Hematolymphoid Disease Management Group, Department of Medical Oncology, Tata Memorial Center, Mumbai, India have just published in Pediatric Blood and Cancer a research article entitled: Treatment of Langerhans cell histiocytosis with a modified risk-adapted protocol-experience from a tertiary cancer institute in India. Involvement of risk-organs (RO+) in Langerhans cell histiocytosis (LCH) and inadequate early response (...)